Bluejay Diagnostics, Inc. (BJDX)

NASDAQ: BJDX · IEX Real-Time Price · USD

0.530

-0.008 (-1.45%)

At close: May 2, 2024, 4:00 PM

0.547

+0.017 (3.21%)

After-hours: May 3, 2024, 4:00 PM EDT

Bluejay Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-9.95	-9.3	-3.49	-1.16	-0.82
Depreciation & Amortization	0.78	0.31	0.15	0.16	0.14
Share-Based Compensation	0.19	0.43	0.07	0.01	0.01
Other Operating Activities	0.67	0.82	-1.09	0.49	-1.03
Operating Cash Flow	-8.31	-7.74	-4.37	-0.51	-1.69
Capital Expenditures	-0.7	-1.2	-0.02	0	-0.01
Investing Cash Flow	-0.7	-1.2	-0.02	0	-0.01
Share Issuance / Repurchase	1.18	0.03	18.89	0	0
Debt Issued / Paid	-0	-0	3.64	0.27	-0.27
Other Financing Activities	-0.06	-0.02	-	1.06	1.78
Financing Cash Flow	1.11	0.01	22.53	1.33	1.51
Net Cash Flow	-7.91	-8.93	18.14	0.82	-0.18
Free Cash Flow	-9.02	-8.94	-4.39	-0.51	-1.7
Free Cash Flow Margin	-	-3590.13%	-	-	-
Free Cash Flow Per Share	-8.22	-8.87	-10.30	-3.23	-10.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).